Stephen Engelberg was the founding managing editor of ProPublica from 2008–2012, and became editor-in-chief on January 1, 2013. He came to ProPublica from The Oregonian in Portland, where he had been a managing editor since 2002. Before joining The Oregonian, Mr. Engelberg worked for The New York Times for 18 years, including stints in Washington, D.C., and Warsaw, Poland, as well as in New York. He is a member of the Pulitzer Prize Board.
Mr. Engelberg’s work since 1996 has focused largely on the editing of investigative projects. He started the Times’s investigative unit in 2000. Projects he supervised at the Times on Mexican corruption (published in 1997) and the rise of Al Qaeda (published beginning in January 2001) were awarded the Pulitzer Prize. During his years at The Oregonian, the paper won the Pulitzer for breaking news and was a finalist for its investigative work on methamphetamines and charities intended to help the disabled. He is the co-author of “Germs: Biological Weapons and America’s Secret War” (2001).
The cause of investigative reporting, a crucial element of our democracy, benefits enormously from our country’s tradition of a free, unfettered press.
Much has changed since ProPublica published its first story, but we remain committed to the power of fact-based journalism to spur change and right wrongs.
While most of her career as a CIA operative remains secret, newly available documents shed light on a pivotal moment in the career of President Donald Trump’s choice to head the nation’s spy agency.
The Veterans Administration refused to release what it had learned about possible links between birth defects and exposure to Agent Orange. ProPublica and The Virginian-Pilot found a novel way to obtain the information under procedures historically used for scientific research by academic scholars.
Federal officials are taking a close look at a sales practice that allows advertisers on the social network to include or exclude people who have an “affinity” with specific ethnic groups.
The recent series of terror attacks in France and Belgium lay bare an array of security shortcomings, most of which remain unaddressed. ProPublica and Frontline examine what went wrong and why it is so hard for Europe to protect itself from the growing threat.
An article in The Atlantic on post-9/11 America makes a powerful case that the “never again” approach to homeland security is good politics but lousy policy.
Unlike many films about reporters, “Spotlight” accurately depicts the frustrations and joys of breaking a big story, from the drudgery of spreadsheets to the electric thrill of revelatory interviews.
A frightened young woman left her apartment in Munich in November 1938 and returned with the visa that saved her family. A team of German journalists launched an improbable search to find the missing artwork and tell its story.
The think tank claims Scorecard’s methods aren’t reliable, but its commentary is undermined by supposition, conflicts of interest and a lack of evidence.
Critics claim our analysis of surgical complications is flawed. We disagree. For the first time, patients can see a surgeon’s record – and use it to help make their best choice.
Thank you for your interest in republishing this story. You are are free to republish it so long as you do the following:
You have to credit us. In the byline, we prefer “Author Name, ProPublica.” At the top of the text of your story, include a line that reads: “This story was originally published by ProPublica.” You must link the word “ProPublica” to the original URL of the story.
If you’re republishing online, you must link to the URL of this story on propublica.org, include all of the links from our story, including our newsletter sign up language and link, and use our PixelPing tag.
If you use canonical metadata, please use the ProPublica URL. For more information about canonical metadata, refer to this Google SEO link.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week,” and “Portland, Ore.” to “Portland” or “here.”)
You cannot republish our photographs or illustrations without specific permission. Please contact [email protected].
It’s okay to put our stories on pages with ads, but not ads specifically sold against our stories. You can’t state or imply that donations to your organization support ProPublica’s work.
You can’t sell our material separately or syndicate it. This includes publishing or syndicating our work on platforms or apps such as Apple News, Google News, etc.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually. (To inquire about syndication or licensing opportunities, contact [email protected].)
You can’t use our work to populate a website designed to improve rankings on search engines or solely to gain revenue from network-based advertisements.
We do not generally permit translation of our stories into another language.
Any website our stories appear on must include a prominent and effective way to contact you.
If you share republished stories on social media, we’d appreciate being tagged in your posts. We have official accounts for ProPublica on Twitter, Facebook and Instagram.
Copy and paste the following into your page to republish:
